Inventor · disambiguated record
Christine Brender Read
Also filed as: READ CHRISTINE BRENDER
8 granted patents·1 pending application·43 citations·filing 2012–2021
84Inventor score
Top patents by PatentIndex Score
9 records- 0193US9000127B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2012·Granted Apr 7, 2015·23 cites·14 claims
- 0292US9550830B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2013·Granted Jan 24, 2017·12 cites·8 claims
- 0385US10189904B2Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2016·Granted Jan 29, 2019·2 cites·14 claims
- 0484US10906975B2Methods of treating autoimmune disease or chronic inflammation with antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK AS·Filed 2018·Granted Feb 2, 2021·2 cites·2 claims
- 0580US9663568B2Antibodies that bind peptidoglycan recognition protein 1NOVO NORDISK AS·Filed 2012·Granted May 30, 2017·4 cites·14 claims
- 0673US11858992B2Nucleic acids encoding antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)NOVO NORDISK·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 0756US10906965B2Methods of treating autoimmune disease or chronic inflammation wtih antibodies that bind peptidoglycan recognition protein 1NOVO NORDISK AS·Filed 2018·Granted Feb 2, 2021·0 cites·6 claims
- 0856US10150809B2Antibodies that bind peptidoglycan recognition protein 1NOVO NORDISK AS·Filed 2017·Granted Dec 11, 2018·0 cites·20 claims
- 0945US2015274825A1Antibodies that Bind and Block Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1)NOVO NORDISK AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Brender Read files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →